Rising incidence of infertility is likely to boost the global assisted reproductive technology market in the years to come. Assisted reproductive technology (ART) is widely utilized in the treatment of infertility. This technology comprises fertility treatments handling sperms of men and eggs of women. This method of treatment involves removal of eggs from the body of a woman and then mixing it with the sperm of a male to create an embryo. After that, the embryo is then placed back into the body of the woman. IVF or in vitro fertilization is the one of the most effective and popular assisted reproductive technology. Growing popularity of assisted reproductive technology is likely to play an important role in the development of the global assisted reproductive technology market over the period of forecast, from 2017 to 2025. Assisted reproductive technology, however, do not comprise treatments involving only sperm of men, such as intrauterine or artificial insemination, or treatment processes in which women take medicines to trigger increased production of ovum or egg sans the intention of retrieving the eggs. 

assisted reproductive technology market

Assisted reproductive technology procedures sometimes make use of previously frozen embryos, donor sperm, or donor eggs. It might also comprise gestational carrier or surrogacy process. A surrogate is the woman who is impregnated by the sperm of a male, one of the intended parents. After childbirth, the newborn is handed over to the intended parents of the child. However, with traditional surrogacy comp locations arise due to the developing relationship between the surrogate mother and the child. In the other process, gestational carrier is impregnated with the sperm of the intended father and egg of the intended mother. Growing popularity of these methods to treat infertility is likely to propel growth of the global assisted reproductive technology market in the years to come. 

One of the most common complications of this procedure is multiple pregnancies. The incidences of multiple pregnancy cane be minimized or prevented by restricting the number of embryos that the placed inside the body of a woman.

The global assisted reproductive technology market is likely to suffer a setback due t spread of coronavirus across the globe. With job cuts and dwindling profits of organizations, people are left with less income, which is likely to adversely affect the expansion of the global assisted reproductive technology market during this ongoing crisis.

Some of the leading firms in the global assisted reproductive technology market comprise Cooper Surgical Inc., Thermo Fisher Scientific, Nidacon International AB, Irvine Scientific, Hamilton Thorne, Inc., and Microm UK Limited. These companies make use of various strategies such as merger and acquisitions, regional expansion, and research and development activities for new technologies and treatment methods.

Rising Cases of Infertility amongst Men and Women to Bolster Demand in the Market

Increased prevalence of infertility across the globe is likely to shape the contours of the global assisted reproductive technology market in the years to come. A few of the latest developments that have taken place in the field of assisted reproductive technology are now widely made available to the couples trying to have a child. These technologies comprise Endometrial Receptivity Array (ERA), DNA Fragmentation Index (DFI), Time Lapse Embryoscope, Egg Vitrification, INVOcell, Preimplantation Genetic Diagnosis (PGD), and Preimplantation genetic screening (PGS).

Of all of these, DNA fragmentation index is becoming increasingly popular. The quality of sperm is determine through several factors, such as morphology, motility, and sperm concentration. DNA fragmentation offers an accurate indication toward infertility of men and it can support the usual, existing procedures of infertility determination. Researchers discovered a correlation that exists between high level of DNA fragmentation in sperm and its functioning. This method of testing clearly indicates as to for which of the couples, the Intracytoplasmic Sperm Injection (ICSI) process will bring fruitful results. Such inventions are likely to leave a positive impact on the global assisted reproductive technology market in the near future.

Egg Vitrification has emerged as another popular technology and preferred by a lot of working women. It is a process of freezing tissues or cells and is also known as cryopreservation. This process has undergone developments and now scientists have come up with an advanced process of freezing, called vitrification. This newly developed process of freezing makes use of new cryoprotectants and protects the cell from any kind of damage. This new technology has brought hope for several patients of cancer, who have been rendered infertile by cancer treatment. This high end procedure of cancer treatment has empowered women who can now preserve their fertility and conceive later in life. Such technological advancements are likely to support growth of the global assisted reproductive technology market in the years to come.

Presence of Large Untapped Market to Make Asia Pacific a Highly Lucrative Region

In the global assisted reproductive technology market, Asia Pacific is estimated to come up as one of the highly lucrative regions. Countries in this region still don’t openly talk about infertility. It is still a taboo, for both men and women. Hence, seeking assistance from modern technologies to give birth is still looked down upon in the region. However, there has been rising incidences of infertility with the change in lifestyle. As such, a large chunk of the market remains untapped, which presents immense growth opportunities for the assisted reproductive technology market in Asia Pacific.

North America is estimated to be one of the key contributors in the global assisted reproductive technology market. Growth of the North America market is ascribed to the rapid technological progress together with increased awareness of people about the availability of assisted reproductive technologies. In addition, growing support from the government is likely to act as a growth factor for the assisted reproductive technology market in North America.

Global Assisted Reproductive Technology Market: Overview

The report on the assisted reproductive technology market analyzes the current and future scenario of the global market. Increase in prevalence of infertility, advent of new technology for development of new devices for ART procedure for high success rate, and increase in adoption and awareness for IVF and surrogacy, are the major drivers of the global assisted reproductive technology market.

The assisted reproductive technology market report comprises an elaborate executive summary, which includes a market snapshot that provides information about various segments of the market. It also provides information and data analysis of the global assisted reproductive technology market with respect to the segments based on technology, procedures, end users and geography. A detailed qualitative analysis of drivers and restraints of the market and opportunities has been provided in the market overview section. In addition, the section comprises porters five forces analysis to understand the competitive landscape in the market. This section of the report also provides market attractiveness analysis, by geography and market share analysis by key players, thus presenting a thorough analysis of the overall competitive scenario in the global assisted reproductive technology market.

Global Assisted Reproductive Technology Market: Segmentation

Based on technology type, the assisted reproductive technology market is segmented as in vitro fertilization, artificial insemination, surrogacy and others. The in vitro fertilization is further segmented into intra-cytoplasmic sperm injection (ICSI), and preimplantation genetic diagnosis (PGD). The artificial insemination is segmented into intrauterine insemination (IUI), and intracervical insemination (ICI) and others. The technology market segments have been analyzed based on available approved technology and devices, cost-effectiveness, and preference for technology and procedures by physicians and embryologists. The market size and forecast for each of these segments have been provided for the period from 2015 to 2025, along with their respective CAGRs for the forecast period from 2017 to 2025, considering 2016 as the base year.

Based on procedures, assisted reproductive technology market is segmented into frozen donor, frozen non donor, fresh donor, fresh non donor, and embryo banking. Based on end user, assisted reproductive technology market is segmented into fertility clinics, hospitals and others. The market segments have been extensively analyzed based on demand for technology and procedure, success rate of procedure and available treatment, and geographical coverage. The market size and forecast in terms of US$ Mn for each segment have been provided for the period from 2015 to 2025. The report also provides the compound annual growth rate (CAGR %) for each market segment for the forecast period from 2017 to 2025, considering 2016 as the base year.

Global Assisted Reproductive Technology Market: Geographical and Competitive Dynamics

Geographically, the global assisted reproductive technology market has been categorized into five major regions and the key countries in the respective region: North America (the U.S., Canada), Europe (the U.K., Germany, Russia, France, Spain, Italy, and Rest of Europe), Asia Pacific (Japan, India, China, Australia & New Zealand and Rest of Asia Pacific), Latin America (Brazil, Mexico, and Rest of Latin America) and Middle East & Africa (South Africa, GCC countries and Rest of Middle East & Africa). The market size and forecast for each of these regions and the mentioned countries have been provided for the period from 2015 to 2025, along with their respective CAGRs for the forecast period from 2017 to 2025, considering 2016 as the base year. The research study also covers the competitive scenario in these regions.

The report also profiles major players in the global assisted reproductive technology market based on various attributes such as company overview, financial overview, product portfolio, business strategies, and recent developments. Major players profiled in this report includes Merck KGaA, CooperSurgical, Inc., Irvine Scientific, Vitrolife AB, Hamilton Thorne, Inc., Nidacon International AB, Laboratoire CCD, Planer PLC, Esco Micro Pte. Ltd. (Esco Group), Nikon Corporation and others

The Global Assisted Reproductive Technology Market is segmented as given below:

Technology

  • In Vitro Fertilization
    • Intra-cytoplasmic Sperm Injection (ICSI)
    • Preimplantation Genetic Diagnosis (PGD)
  • Artificial Insemination
    • Intrauterine Insemination (IUI)
    • Intracervical Insemination (ICI)
    • Others
  • Surrogacy
  • Others

Procedure

  • Frozen Donor
  • Frozen Non Donor
  • Fresh Donor
  • Fresh Non Donor
  • Embryo Banking

End User

  • Fertility Clinics
  • Hospitals
  • Others

Geography

  • North America
    • US
    • Canada
  • Europe
    • Germany
    • U.K.
    • Russia
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • India
    • China
    • Australia & New Zealand
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC countries
    • South Africa
    • Rest of Middle East & Africa

Custom Market Research Services

TMR offers custom market research services that help clients to get information on their business scenario required where syndicated solutions are not enough.

REQUEST CUSTOMIZATION

Assisted Reproductive Technology Market

Buy Now